Immunocore (IMCR)
(Delayed Data from NSDQ)
$32.99 USD
+0.22 (0.67%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $33.05 +0.06 (0.18%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Immunocore Holdings PLC Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMCR 32.99 +0.22(0.67%)
Will IMCR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMCR
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
IMCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises
UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales
Other News for IMCR
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025 | ...
Notable Two Hundred Day Moving Average Cross - IMCR
Tracking Baker Brothers Portfolio - Q1 2025 Update
Delcath Systems: Growing Fast, But Business Model Is Fragile
Immunocore Holdings (IMCR): HC Wainwright Maintains Buy Rating | IMCR Stock News